Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.00, read 2026-11-05
Ethical passes the values gate
Price35.36 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-09-24Read Markdown41.67-15.1% to today ✓Distribution gives way to Markdown after a 19% slide in 12 weeks
2026-07-02Read Distribution51.37-31.2% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Astec Industries, Inc. holds its Accumulation at $35.36. The statistical read favours the sellers, held for 41 days.
As held on the ledger · 2026-11-05
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 41 days
Price at the screen
$35.36
Valuation
41.60 trailing · 9.00 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.40
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
25.45%
Below 33%
Interest-bearing debt is just 25.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.15%
Below 33%
Cash held in interest-bearing accounts and securities is 0.2% of assets, under the one-third limit.
Pass
Receivables
21.20%
Below 49%
Money owed to the company is 21.2% of assets, under the 49% limit.
Pass
Revenue purity
0.23%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Astec Industries, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 25%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ASTE's ethical verdict changes
Today ASTE passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Our model's value is 2.04x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Every time a crew paves a highway or crushes rock for new roads the machines come from firms like this one, yet the numbers reveal how little of that activity turns into lasting profit. Revenue is rising 20 percent but margins sit at just 2 percent and return on equity is only 4 percent, leaving the business with limited ability to compound capital even at a forward multiple of 13.1 times. The ethical screen clears, yet the opportunity rating stays at none because the low multiple alone does not signal value in this setting.
Analysts see upside toward 72 dollars from the current 55, and a calculated fair value sits higher still, yet those figures rest on earnings that can swing sharply with public spending cycles. Unknown competitive position and thin returns make it hard to trust that the gap will close rather than widen when orders slow.
Cyclical construction demand often produces exactly this pattern of peak earnings and compressed multiples, creating the appearance of a bargain that later proves expensive once volumes normalise. Currency moves and delayed infrastructure budgets add further uncertainty to any recovery story. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ASTE trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markdown$39.30-1.9%Entry 18
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Markdown$40.06-0.1%Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markdown$40.09+2.1%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markdown$39.27+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markdown$39.27+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markdown$39.27-1.6%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markdown$39.91+2.4%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markdown$38.97+0.2%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown$38.90-0.1%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72.
2026-10-20Markdown$38.92+0.5%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $72.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
